BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9545144)

  • 1. The association between cryptococcal variety and immunocompetent and immunocompromised hosts.
    Peachey PR; Gubbins PO; Martin RE
    Pharmacotherapy; 1998; 18(2):255-64. PubMed ID: 9545144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.
    Chen S; Sorrell T; Nimmo G; Speed B; Currie B; Ellis D; Marriott D; Pfeiffer T; Parr D; Byth K
    Clin Infect Dis; 2000 Aug; 31(2):499-508. PubMed ID: 10987712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
    Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
    Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution of Cryptococcus neoformans serotypes associated with human infections in Argentina].
    Canteros CE; Brudny M; Rodero L; Perrotta D; Davel G
    Rev Argent Microbiol; 2002; 34(4):213-8. PubMed ID: 12600005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization of Cryptococcus neoformans strains isolated from patients with acquired immunodeficiency syndrome (AIDS)].
    Garza-Garza D; Buendía-Uribe JL; Martínez-Cruz E; Argüero-Licea B
    Rev Latinoam Microbiol; 1995; 37(3):273-9. PubMed ID: 8850346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcosis in apparently immunocompetent patients.
    Lui G; Lee N; Ip M; Choi KW; Tso YK; Lam E; Chau S; Lai R; Cockram CS
    QJM; 2006 Mar; 99(3):143-51. PubMed ID: 16504989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cryptococcus species--etiological agents of zoonoses or sapronosis?].
    Blaschke-Hellmessen R
    Mycoses; 2000; 43 Suppl 1():48-60. PubMed ID: 11098627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil.
    Rozenbaum R; Gonçalves AJ; Wanke B; Caiuby MJ; Clemente H; Lazera Mdos S; Monteiro PC; Londero AT
    Mycopathologia; 1992 Sep; 119(3):133-6. PubMed ID: 1435954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008.
    Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C
    Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal meningitis caused by Cryptococcus neoformans var. gattii, serotype C, in AIDS patients in Soweto, South Africa.
    Karstaedt AS; Crewe-Brown HH; Dromer F
    Med Mycol; 2002 Feb; 40(1):7-11. PubMed ID: 11860015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.
    Dromer F; Gueho E; Ronin O; Dupont B
    J Clin Microbiol; 1993 Feb; 31(2):359-63. PubMed ID: 8432823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects.
    Speed BR; Kaldor J; Cairns B; Pegorer M
    J Med Vet Mycol; 1996; 34(3):187-93. PubMed ID: 8803799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans.
    Speed B; Dunt D
    Clin Infect Dis; 1995 Jul; 21(1):28-34; discussion 35-6. PubMed ID: 7578756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of cryptococcosis.
    Ritter M; Goldman DL
    Expert Opin Pharmacother; 2009 Oct; 10(15):2433-43. PubMed ID: 19708853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.
    Calvo BM; Colombo AL; Fischman O; Santiago A; Thompson L; Lazera M; Telles F; Fukushima K; Nishimura K; Tanaka R; Myiajy M; Moretti-Branchini ML
    J Clin Microbiol; 2001 Jun; 39(6):2348-50. PubMed ID: 11376089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcosis in the immunocompromised host with special reference to AIDS.
    Khanna N; Chandramuki A; Desai A; Ravi V; Santosh V; Shankar SK; Satishchandra P
    Indian J Chest Dis Allied Sci; 2000; 42(4):311-5. PubMed ID: 15597679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection caused by Cryptococcus neoformans var. gattii serotype B in an AIDS patient in India.
    Abraham M; Mathews V; Ganesh A; John TJ; Mathews MS
    J Med Vet Mycol; 1997; 35(4):283-4. PubMed ID: 9292426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crytococcus neoformans var. gattii in an AIDS patient: first observation in Mexico.
    Castanón-Olivares LR; Lopez-Martínez R; Barriga-Angulo G; Ríos-Rosas C
    J Med Vet Mycol; 1997; 35(1):57-9. PubMed ID: 9061587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The epidemiological characteristics of 105 cases of cryptococcosis diagnosed in the Republic of Argentina between 1981-1990].
    Bava AJ; Negroni R
    Rev Inst Med Trop Sao Paulo; 1992; 34(4):335-40. PubMed ID: 1342091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.